Cargando…
Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
Among modern drug formulations, stimuli-responsive hydrogels also called “smart hydrogels” deserve a special attention. The basic feature of this system is the ability to change their mechanical properties, swelling ability, hydrophilicity, bioactive molecules permeability, etc., influenced by vario...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326401/ https://www.ncbi.nlm.nih.gov/pubmed/32617004 http://dx.doi.org/10.2147/IJN.S248987 |
_version_ | 1783552334241988608 |
---|---|
author | Kasiński, Adam Zielińska-Pisklak, Monika Oledzka, Ewa Sobczak, Marcin |
author_facet | Kasiński, Adam Zielińska-Pisklak, Monika Oledzka, Ewa Sobczak, Marcin |
author_sort | Kasiński, Adam |
collection | PubMed |
description | Among modern drug formulations, stimuli-responsive hydrogels also called “smart hydrogels” deserve a special attention. The basic feature of this system is the ability to change their mechanical properties, swelling ability, hydrophilicity, bioactive molecules permeability, etc., influenced by various stimuli, such as temperature, pH, electromagnetic radiation, magnetic field and biological factors. Therefore, stimuli-responsive matrices can be potentially used in tissue engineering, cell cultures and technology of innovative drug delivery systems (DDSs), releasing the active substances under the control of internal or external stimuli. Moreover, smart hydrogels can be used as injectable DDSs, due to gel–sol transition connected with in situ cross-linking process. Innovative smart hydrogel DDSs can be utilized as matrices for targeted therapy, which enhances the effectiveness of tumor chemotherapy and subsequently limits systemic toxicity. External stimulus sensitivity allows remote control over the drug release profile and gel formation. On the other hand, internal factors provide drg accumulation in tumor tissue and reduce the concentration of active drug form in healthy tissue. In this report, we summarise the basic knowledge and chemical strategies for the synthetic smart hydrogel DDSs applied in antitumor therapy. |
format | Online Article Text |
id | pubmed-7326401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-73264012020-07-01 Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems Kasiński, Adam Zielińska-Pisklak, Monika Oledzka, Ewa Sobczak, Marcin Int J Nanomedicine Review Among modern drug formulations, stimuli-responsive hydrogels also called “smart hydrogels” deserve a special attention. The basic feature of this system is the ability to change their mechanical properties, swelling ability, hydrophilicity, bioactive molecules permeability, etc., influenced by various stimuli, such as temperature, pH, electromagnetic radiation, magnetic field and biological factors. Therefore, stimuli-responsive matrices can be potentially used in tissue engineering, cell cultures and technology of innovative drug delivery systems (DDSs), releasing the active substances under the control of internal or external stimuli. Moreover, smart hydrogels can be used as injectable DDSs, due to gel–sol transition connected with in situ cross-linking process. Innovative smart hydrogel DDSs can be utilized as matrices for targeted therapy, which enhances the effectiveness of tumor chemotherapy and subsequently limits systemic toxicity. External stimulus sensitivity allows remote control over the drug release profile and gel formation. On the other hand, internal factors provide drg accumulation in tumor tissue and reduce the concentration of active drug form in healthy tissue. In this report, we summarise the basic knowledge and chemical strategies for the synthetic smart hydrogel DDSs applied in antitumor therapy. Dove 2020-06-25 /pmc/articles/PMC7326401/ /pubmed/32617004 http://dx.doi.org/10.2147/IJN.S248987 Text en © 2020 Kasiński et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Kasiński, Adam Zielińska-Pisklak, Monika Oledzka, Ewa Sobczak, Marcin Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems |
title | Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems |
title_full | Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems |
title_fullStr | Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems |
title_full_unstemmed | Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems |
title_short | Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems |
title_sort | smart hydrogels – synthetic stimuli-responsive antitumor drug release systems |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326401/ https://www.ncbi.nlm.nih.gov/pubmed/32617004 http://dx.doi.org/10.2147/IJN.S248987 |
work_keys_str_mv | AT kasinskiadam smarthydrogelssyntheticstimuliresponsiveantitumordrugreleasesystems AT zielinskapisklakmonika smarthydrogelssyntheticstimuliresponsiveantitumordrugreleasesystems AT oledzkaewa smarthydrogelssyntheticstimuliresponsiveantitumordrugreleasesystems AT sobczakmarcin smarthydrogelssyntheticstimuliresponsiveantitumordrugreleasesystems |